Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01770028 · ClinicalTrials.gov registry record

Ripple Effect of Lifestyle Intervention During Pregnancy on Partners' Weight

A clinical trial of Obesity, sponsored by California Polytechnic State University-San Luis Obispo.

Completed
Registry status
122
Enrollment target
3
Study locations

NCT01770028 is a study of Obesity that has completed, run by California Polytechnic State University-San Luis Obispo. The registered enrollment target is 122 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01770028, a study of Obesity, has completed, sponsored by California Polytechnic State University-San Luis Obispo.

COMPLETED
Registry status
122 participants
Enrollment target
3
Study locations

Study Summary

The primary aim of the proposed study is to determine whether lifestyle interventions to prevent excessive gestational weight gain in overweight/obese pregnant women have positive "ripple" effects on untreated partners in the home. We hypothesize that partners of pregnant women randomized to the lifestyle intervention, relative to those of standard care, will have greater weight losses through 12-months. Secondary aims examine partner improvements in weight control behaviors, the home environment, and psychosocial parameters.

Conditions Studied

Study Locations (3)

California

  • California Polytechnic State University - San Luis Obispo

New York

  • Columbia University - New York

Rhode Island

  • Miriam Hospital - Providence

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2013-01
Est. Completion 2017-07

What the Registry Record Tells You About NCT01770028

The ClinicalTrials.gov registry entry for NCT01770028 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower). The listed sponsor is California Polytechnic State University-San Luis Obispo, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 0 interventions.

NCT01770028 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, New York, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT01770028 about?

NCT01770028 is a clinical study titled "Ripple Effect of Lifestyle Intervention During Pregnancy on Partners' Weight". The primary aim of the proposed study is to determine whether lifestyle interventions to prevent excessive gestational weight gain in overweight/obese pregnant women have positive "ripple" effects on untreated partners in the home. We hypothesize that partners of pregnant women randomized to the lif...

What is the current status of trial NCT01770028?

This trial is currently completed. The enrollment target is 122 participants. The study started on 2013-01. Estimated completion is 2017-07.

What conditions does trial NCT01770028 study?

This clinical trial studies the following conditions: Obesity.

Who is sponsoring clinical trial NCT01770028?

This trial is sponsored by California Polytechnic State University-San Luis Obispo, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01770028 being conducted?

This trial has 3 study locations across California, New York, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.